{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:57:31Z","timestamp":1792519051907,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ccc.2023.12.004","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T09:13:42Z","timestamp":1703322822000},"page":"329-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adjunctive Therapies in Acute Respiratory Distress Syndrome"],"prefix":"10.1016","volume":"40","author":[{"given":"Megan","family":"Trieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7511","key":"10.1016\/j.ccc.2023.12.004_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(67)90168-7","article-title":"Acute respiratory distress in adults","volume":"2","author":"Ashbaugh","year":"1967","journal-title":"Lancet Lond Engl"},{"issue":"18","key":"10.1016\/j.ccc.2023.12.004_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","author":"Acute Respiratory Distress Syndrome Network","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jama.2010.218","article-title":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis","volume":"303","author":"Briel","year":"2010","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jama.2019.0555","volume":"321","author":"Beitler","year":"2019","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.ccc.2023.12.004_bib5","first-page":"2564","article-title":"National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et\u00a0al. Comparison of two fluid-management strategies in acute lung injury","volume":"354","author":"National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome ARDS Clinical Trials Network","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccc.2023.12.004_bib6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccc.2023.12.004_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/rccm.200506-899OC","article-title":"Prone position augments recruitment and prevents alveolar overinflation in acute lung injury","volume":"174","author":"Galiatsou","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13054-019-2365-1","article-title":"Recruitment maneuvers and higher PEEP, the so-called open lung concept, in patients with ARDS","volume":"23","author":"van der Zee","year":"2019","journal-title":"Crit Care Lond Engl"},{"issue":"11","key":"10.1016\/j.ccc.2023.12.004_bib9","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1164\/rccm.201308-1532CI","article-title":"Prone position in acute respiratory distress syndrome. Rationale, indications, and limits","volume":"188","author":"Gattinoni","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccc.2023.12.004_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa010043","article-title":"Effect of prone positioning on the survival of patients with acute respiratory failure","volume":"345","author":"Gattinoni","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib11","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1503\/cmaj.071802","article-title":"Effect of mechanical ventilation in the prone position on clinical outcomes in patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis","volume":"178","author":"Sud","year":"2008","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"issue":"18","key":"10.1016\/j.ccc.2023.12.004_bib12","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.2009.1614","article-title":"Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial","volume":"302","author":"Taccone","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccc.2023.12.004_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.CCM.0000299739.98236.05","article-title":"Effect of prone positioning in patients with acute respiratory distress syndrome: a meta-analysis","volume":"36","author":"Alsaghir","year":"2008","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib14","first-page":"448","article-title":"Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-analysis","volume":"76","author":"Gattinoni","year":"2010","journal-title":"Minerva Anestesiol"},{"issue":"23","key":"10.1016\/j.ccc.2023.12.004_bib15","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Gu\u00e9rin","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"Supplement_4","key":"10.1016\/j.ccc.2023.12.004_bib16","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1513\/AnnalsATS.201704-343OT","article-title":"Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis","volume":"14","author":"Munshi","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"10.1016\/j.ccc.2023.12.004_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/08850666211014479","article-title":"Multivariate meta-analysis of the mortality effect of prone positioning in the acute respiratory distress syndrome","volume":"36","author":"Moran","year":"2021","journal-title":"J\u00a0Intensive Care Med"},{"issue":"7","key":"10.1016\/j.ccc.2023.12.004_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","article-title":"ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","volume":"49","author":"Grasselli","year":"2023","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201703-0548ST","article-title":"An official American thoracic society\/European society of intensive care medicine\/society of critical care medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome","volume":"195","author":"Fan","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccc.2023.12.004_bib20","article-title":"An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline","author":"Qadir","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2023.12.004_bib21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/rccm.201311-2056LE","article-title":"Prone position-induced improvement in gas exchange does not predict improved survival in the acute respiratory distress syndrome","volume":"189","author":"Albert","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2023.12.004_bib22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.chest.2021.05.047","article-title":"Variation in early management practices in moderate-to-severe ARDS in the United States: the severe ARDS: generating evidence study","volume":"160","author":"Qadir","year":"2021","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.chest.2020.01.041","article-title":"Patterns of use of adjunctive therapies in patients with early moderate to severe ARDS: insights from the LUNG SAFE study","volume":"157","author":"Duggal","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","article-title":"Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study","volume":"47","year":"2021","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.ccc.2023.12.004_bib25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US","volume":"180","author":"Gupta","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00134-017-4996-5","article-title":"A\u00a0prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study","volume":"44","author":"Gu\u00e9rin","year":"2018","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.chest.2020.03.022","article-title":"Adjunctive therapies in ARDS: the disconnect between clinical trials and clinical practice","volume":"157","author":"Qadir","year":"2020","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199802053380602","article-title":"Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome","volume":"338","author":"Amato","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.299.6.637","article-title":"Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial","volume":"299","author":"Meade","year":"2008","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.ccc.2023.12.004_bib30","first-page":"3100","article-title":"Clinical efficacy and safety of recruitment maneuver in patients with acute respiratory distress syndrome using low tidal volume ventilation: a multicenter randomized controlled clinical trial","volume":"123","author":"Xi","year":"2010","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"10.1016\/j.ccc.2023.12.004_bib31","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00134-011-2323-0","article-title":"Optimal duration of a sustained inflation recruitment maneuver in ARDS patients","volume":"37","author":"Arnal","year":"2011","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.ccc.2023.12.004_bib32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S2213-2600(19)30138-9","article-title":"Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial","volume":"7","author":"Constantin","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.ccc.2023.12.004_bib33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1164\/ajrccm.159.3.9802090","article-title":"Sigh in acute respiratory distress syndrome","volume":"159","author":"Pelosi","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2023.12.004_bib34","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.chest.2020.10.079","article-title":"Sigh in patients with acute hypoxemic respiratory failure and ARDS","volume":"159","author":"Mauri","year":"2021","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccc.2023.12.004_bib35","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/cc10249","article-title":"A\u00a0randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome","volume":"15","author":"Hodgson","year":"2011","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0885066610383953","article-title":"A\u00a0positive response to a recruitment maneuver with PEEP titration in patients with ARDS, regardless of transient oxygen desaturation during the maneuver","volume":"26","author":"Hodgson","year":"2011","journal-title":"J\u00a0Intensive Care Med"},{"issue":"12","key":"10.1016\/j.ccc.2023.12.004_bib37","first-page":"1167","article-title":"Acute physiologic effects of a stepwise recruitment maneuver in acute respiratory distress syndrome","volume":"77","author":"Mor\u00e1n","year":"2011","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/CCM.0000000000001383","article-title":"Open lung approach for the acute respiratory distress syndrome: a pilot, randomized controlled trial","volume":"44","author":"Kacmarek","year":"2016","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccc.2023.12.004_bib39","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1097\/01.CCM.0000090001.91640.45","article-title":"Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure","volume":"31","author":"Brower","year":"2003","journal-title":"Crit Care Med"},{"issue":"14","key":"10.1016\/j.ccc.2023.12.004_bib40","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.2017.14171","volume":"318","author":"Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial ART Investigators","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ccc.2023.12.004_bib41","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1164\/rccm.201901-0109OC","article-title":"Maximal recruitment open lung ventilation in acute respiratory distress syndrome (PHARLAP). A phase II, multicenter randomized controlled clinical trial","volume":"200","author":"Hodgson","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.ccc.2023.12.004_bib42","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00134-019-05821-9","article-title":"Effect of lung recruitment maneuver on oxygenation, physiological parameters and mortality in acute respiratory distress syndrome patients: a systematic review and meta-analysis","volume":"45","author":"Pensier","year":"2019","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib43","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.ccc.2023.12.004_bib44","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/106002809603001213","article-title":"Acute myopathy associated with combined use of corticosteroids and neuromuscular blocking agents","volume":"30","author":"Fischer","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ccc.2023.12.004_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcrc.2016.09.018","article-title":"Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: a historical review","volume":"37","author":"Wilcox","year":"2017","journal-title":"J\u00a0Crit Care"},{"issue":"4","key":"10.1016\/j.ccc.2023.12.004_bib46","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ccc.2021.05.009","article-title":"Pharmacologic treatments for acute respiratory distress syndrome","volume":"37","author":"Qadir","year":"2021","journal-title":"Crit Care Clin"},{"issue":"12","key":"10.1016\/j.ccc.2023.12.004_bib47","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","article-title":"Neuromuscular blockers in early acute respiratory distress syndrome","volume":"363","author":"Papazian","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ccc.2023.12.004_bib48","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJMoa1901686","article-title":"Early neuromuscular blockade in the acute respiratory distress syndrome","volume":"380","author":"National Heart","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccc.2023.12.004_bib49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40560-020-0431-z","article-title":"Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Ho","year":"2020","journal-title":"J\u00a0Intensive Care"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.23736\/S0375-9393.19.13436-0","article-title":"Patient-ventilator asynchrony in adult critically ill patients","volume":"85","author":"Bruni","year":"2019","journal-title":"Minerva Anestesiol"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib51","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib52","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccc.2023.12.004_bib53","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ccc.2023.12.004_bib54","article-title":"Corticosteroids for pneumonia. Cochrane acute respiratory infections group","volume":"2017","author":"Stern","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"10.1016\/j.ccc.2023.12.004_bib55","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.ccc.2023.12.004_bib56","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","article-title":"High-dose corticosteroids in patients with the adult respiratory distress syndrome","volume":"317","author":"Bernard","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccc.2023.12.004_bib57","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial","volume":"131","author":"GU","year":"2007","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccc.2023.12.004_bib58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccc.2023.12.004_bib59","first-page":"53","article-title":"Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS","volume":"6","author":"GU","year":"2018","journal-title":"J\u00a0Intensive Care"},{"issue":"5","key":"10.1016\/j.ccc.2023.12.004_bib60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","article-title":"Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis","volume":"47","author":"Chaudhuri","year":"2021","journal-title":"Intensive Care Med"},{"issue":"16","key":"10.1016\/j.ccc.2023.12.004_bib61","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccc.2023.12.004_bib62","doi-asserted-by":"crossref","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","author":"Waljee","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ccc.2023.12.004_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/CLEP.S341048","article-title":"Glucocorticoids and risk of venous thromboembolism in asthma patients aged 20-59 Years in the United Kingdom\u2019s CPRD 1995-2015","volume":"14","author":"Ayodele","year":"2022","journal-title":"Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.ccc.2023.12.004_bib64","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/CCM.0000000000002737","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of critical care medicine (SCCM) and European society of intensive care medicine (ESICM) 2017","volume":"45","author":"Annane","year":"2017","journal-title":"Crit Care Med"},{"issue":"6 Pt 1","key":"10.1016\/j.ccc.2023.12.004_bib65","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1164\/ajrccm.154.6.8970353","article-title":"Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome","volume":"154","author":"Zwissler","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2023.12.004_bib66","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1164\/ajrccm.153.3.8630585","article-title":"Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome","volume":"153","author":"Walmrath","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 Pt 1","key":"10.1016\/j.ccc.2023.12.004_bib67","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1164\/ajrccm.157.6.9609017","article-title":"Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome","volume":"157","author":"Putensen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"25","key":"10.1016\/j.ccc.2023.12.004_bib68","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMra051884","article-title":"Inhaled nitric oxide therapy in adults","volume":"353","author":"Griffiths","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7597","key":"10.1016\/j.ccc.2023.12.004_bib69","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.39139.716794.55","article-title":"Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis","volume":"334","author":"Adhikari","year":"2007","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib70","first-page":"CD002787","article-title":"Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults","volume":"2016","author":"Gebistorf","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ccc.2023.12.004_bib71","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.2108121","article-title":"Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study","volume":"167","author":"Gerlach","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib72","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-016-1566-0","article-title":"Inhaled nitric oxide and the risk of renal dysfunction in patients with acute respiratory distress syndrome: a propensity-matched cohort study","volume":"20","author":"Ruan","year":"2016","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.12-2296","article-title":"Iloprost improves gas exchange in patients with pulmonary hypertension and ARDS","volume":"144","author":"Sawheny","year":"2013","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ccc.2023.12.004_bib74","first-page":"CD007733","article-title":"Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS)","volume":"7","author":"Afshari","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib75","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2019.9302","article-title":"Extracorporeal life support for adults with respiratory failure and related indications: a review","volume":"322","author":"Brodie","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2023.12.004_bib76","unstructured":"Organization ELS. ECLS Registry Report: International Summary.; 2023. https:\/\/www.elso.org\/registry\/internationalsummaryandreports\/reports.aspx."},{"issue":"9698","key":"10.1016\/j.ccc.2023.12.004_bib77","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(09)61069-2","article-title":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial","volume":"374","author":"Peek","year":"2009","journal-title":"Lancet Lond Engl"},{"issue":"21","key":"10.1016\/j.ccc.2023.12.004_bib78","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ccc.2023.12.004_bib79","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1056\/NEJMe1805123","article-title":"Learning from a trial stopped by a data and safety monitoring board","volume":"378","author":"Harrington","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ccc.2023.12.004_bib80","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2018.14276","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial","volume":"320","author":"Goligher","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccc.2023.12.004_bib81","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2213-2600(18)30452-1","article-title":"Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"7","author":"Munshi","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib82","first-page":"601","article-title":"Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the extracorporeal life support organization (ELSO)","volume":"67","author":"Tonna","year":"2021","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"issue":"11","key":"10.1016\/j.ccc.2023.12.004_bib83","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1164\/rccm.201311-2023OC","article-title":"Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score","volume":"189","author":"Schmidt","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccc.2023.12.004_bib84","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1007\/s00134-013-3037-2","article-title":"The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","volume":"39","author":"Schmidt","year":"2013","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2023.12.004_bib85","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0885066617737035","article-title":"Long-term quality of life after extracorporeal membrane oxygenation in ARDS survivors: systematic review and meta-analysis","volume":"35","author":"Wilcox","year":"2020","journal-title":"J\u00a0Intensive Care Med"},{"issue":"8","key":"10.1016\/j.ccc.2023.12.004_bib86","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.201409-1634OC","article-title":"Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry","volume":"191","author":"Barbaro","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib87","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.surg.2023.02.004","article-title":"A\u00a0contemporary analysis of the volume-outcome relationship for extracorporeal membrane oxygenation in the United States","volume":"173","author":"Verma","year":"2023","journal-title":"Surgery"},{"issue":"13","key":"10.1016\/j.ccc.2023.12.004_bib88","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccc.2023.12.004_bib89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.280.2.159","article-title":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial","volume":"280","author":"Meduri","year":"1998","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib90","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; metcovid): a randomized, double-blind, phase IIb, placebo-controlled trial","volume":"72","author":"Jeronimo","year":"2021","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib91","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.CCM.0000194723.78632.62","article-title":"Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome","volume":"34","author":"Annane","year":"2006","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib92","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","article-title":"Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial","volume":"20","author":"Tongyoo","year":"2016","journal-title":"Crit Care Lond Engl"},{"issue":"13","key":"10.1016\/j.ccc.2023.12.004_bib93","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib94","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A\u00a0pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.ccc.2023.12.004_bib95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2466-12-5","article-title":"A\u00a0phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome","volume":"12","author":"Morris","year":"2012","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.ccc.2023.12.004_bib96","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1164\/rccm.200508-1302OC","article-title":"The beta-agonist lung injury trial (Balti): a randomized placebo-controlled clinical trial","volume":"173","author":"Perkins","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccc.2023.12.004_bib97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/rccm.201012-2090OC","article-title":"National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Matthay MA, Brower RG, et\u00a0al. Randomized, placebo-controlled clinical trial of an aerosolized \u03b2\u2082-agonist for treatment of acute lung injury","volume":"184","author":"National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome ARDS Clinical Trials Network","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"9812","key":"10.1016\/j.ccc.2023.12.004_bib98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(11)61623-1","article-title":"Effect of intravenous \u03b2-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (Balti-2): a multicentre, randomised controlled trial","volume":"379","author":"Gao Smith","year":"2012","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"10.1016\/j.ccc.2023.12.004_bib99","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/CCM.0000000000002284","article-title":"Randomized clinical trial of a combination of an inhaled corticosteroid and beta agonist in patients at risk of developing the acute respiratory distress syndrome","volume":"45","author":"Festic","year":"2017","journal-title":"Crit Care Med"},{"issue":"23","key":"10.1016\/j.ccc.2023.12.004_bib100","doi-asserted-by":"crossref","first-page":"e124039","DOI":"10.1172\/jci.insight.124039","article-title":"A\u00a0phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS","volume":"3","author":"Fredenburgh","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003246-200001000-00001","article-title":"Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte\/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome","volume":"28","author":"Matute-Bello","year":"2000","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccc.2023.12.004_bib102","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.2009005","article-title":"A\u00a0randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction","volume":"166","author":"Presneill","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib103","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/CCM.0b013e31822d7bf0","article-title":"A\u00a0randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury","volume":"40","author":"Paine","year":"2012","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2023.12.004_bib104","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/cc6894","article-title":"A\u00a0phase 1 trial of nebulised heparin in acute lung injury","volume":"12","author":"Dixon","year":"2008","journal-title":"Crit Care Lond Engl"},{"issue":"5","key":"10.1016\/j.ccc.2023.12.004_bib105","doi-asserted-by":"crossref","first-page":"R180","DOI":"10.1186\/cc9286","article-title":"Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial","volume":"14","author":"Dixon","year":"2010","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib106","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0310057X1604400106","article-title":"A\u00a0trial of nebulised heparin to limit lung injury following cardiac surgery","volume":"44","author":"Dixon","year":"2016","journal-title":"Anaesth Intensive Care"},{"issue":"2","key":"10.1016\/j.ccc.2023.12.004_bib107","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1053\/j.jvca.2019.05.035","article-title":"Streptokinase versus unfractionated heparin nebulization in patients with severe acute respiratory distress syndrome (ARDS): a randomized controlled trial with observational controls","volume":"34","author":"Abdelaal Ahmed Mahmoud","year":"2020","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1016\/j.ccc.2023.12.004_bib108","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S2213-2600(13)70259-5","article-title":"The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study","volume":"2","author":"Bellingan","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.ccc.2023.12.004_bib109","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.2019.22525","article-title":"Effect of intravenous interferon \u03b2-1a on death and days free from mechanical ventilation among patients with moderate to severe acute respiratory distress syndrome: a randomized clinical trial","volume":"323","author":"Ranieri","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.ccc.2023.12.004_bib111","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccc.2023.12.004_bib112","series-title":"B14. Late BREAKING clinical trials","first-page":"A7353","article-title":"Primary analysis of a phase 1\/2 study to assess MultiStem\u00ae cell therapy, a regenerative advanced therapy medicinal product (ATMP), in acute respiratory distress syndrome (MUST-ARDS)","author":"Bellingan","year":"2019"},{"issue":"5","key":"10.1016\/j.ccc.2023.12.004_bib113","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1097\/CCM.0000000000004285","article-title":"Human umbilical cord-derived mesenchymal stem cells for acute respiratory distress syndrome","volume":"48","author":"Yip","year":"2020","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccc.2023.12.004_bib114","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/sctm.20-0472","article-title":"Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1\/2a, randomized controlled trial","volume":"10","author":"Lanzoni","year":"2021","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"10.1016\/j.ccc.2023.12.004_bib115","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00003246-199207000-00004","article-title":"Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study","volume":"20","author":"Jepsen","year":"1992","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib116","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1378\/chest.105.1.190","article-title":"N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study","volume":"105","author":"Suter","year":"1994","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib117","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1378\/chest.112.1.164","article-title":"A\u00a0trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group","volume":"112","author":"Bernard","year":"1997","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccc.2023.12.004_bib118","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0883-9441(97)90029-0","article-title":"Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study","volume":"12","author":"Domenighetti","year":"1997","journal-title":"J\u00a0Crit Care"},{"issue":"6","key":"10.1016\/j.ccc.2023.12.004_bib119","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1007\/s43440-021-00296-2","article-title":"A\u00a0pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome","volume":"73","author":"Taher","year":"2021","journal-title":"Pharmacol Rep PR"},{"issue":"3","key":"10.1016\/j.ccc.2023.12.004_bib120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jcph.203","article-title":"A\u00a0FIM study to assess safety and exposure of inhaled single doses of AP301-A specific ENaC channel activator for the treatment of acute lung injury","volume":"54","author":"Schwameis","year":"2014","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ccc.2023.12.004_bib121","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13054-017-1795-x","article-title":"Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial","volume":"21","author":"Krenn","year":"2017","journal-title":"Crit Care Lond Engl"},{"issue":"23","key":"10.1016\/j.ccc.2023.12.004_bib122","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome","volume":"370","author":"National Heart","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.ccc.2023.12.004_bib123","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"Simvastatin in the acute respiratory distress syndrome","volume":"371","author":"McAuley","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccc.2023.12.004_bib124","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/thoraxjnl-2015-208017","article-title":"One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial","volume":"71","author":"Dinglas","year":"2016","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"22","key":"10.1016\/j.ccc.2023.12.004_bib126","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM199605303342201","article-title":"Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf acute respiratory distress syndrome sepsis study group","volume":"334","author":"Anzueto","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccc.2023.12.004_bib127","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa033181","article-title":"Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome","volume":"351","author":"Spragg","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccc.2023.12.004_bib128","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.201009-1424OC","article-title":"Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury","volume":"183","author":"Spragg","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccc.2023.12.004_bib129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1378\/chest.14-1139","article-title":"The adult calfactant in acute respiratory distress syndrome trial","volume":"148","author":"Willson","year":"2015","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.ccc.2023.12.004_bib130","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.11825","article-title":"Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial","volume":"322","author":"Fowler","year":"2019","journal-title":"JAMA"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070423000945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070423000945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:33:20Z","timestamp":1760063600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070423000945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":130,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0749070423000945"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2023.12.004","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive Therapies in Acute Respiratory Distress Syndrome","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}